Key result
Heart failure is linked to a ~4-fold higher 30-day readmission risk in IBD patients.
Why the study?
Readmissions are increasingly used as a quality of care indicator, but risk factors for 30-day readmission in hospitalized inflammatory bowel disease patients are not well defined.
Cohort (n=498)
No
Odds Ratio: 4.06
In patients hospitalized with inflammatory bowel disease, comorbid conditions like congestive heart failure and COPD, as well as malnutrition and obesity, significantly increase the risk of 30-day readmission.
May support comorbidity-based risk stratification in IBD admissions; leaves open whether targeted interventions reduce 30-day readmissions.
BACKGROUND: Readmissions are being increasingly used as an indicator of quality of care. We sought to identify risk factors for 30-day readmission in hospitalized patients with inflammatory bowel disease. METHODS: Patients with inflammatory bowel disease hospitalized between 2004 and 2013 at the University of Maryland were identified. Demographic and clinical information were extracted from the medical record for each admission. Multivariate logistic regression was performed to determine the association between these variables and readmission. RESULTS: One thousand two hundred thirteen admissions were identified in 498 patients; 232 (19.1%) index admissions were followed by a 30-day readmission. Mean age was 39.4 ± 14.5 years. Approximately 70% of the population was white, 60% were women, and 67.5% had Crohn's disease. Concurrent congestive heart failure and chronic obstructive pulmonary disease, history of steroid use, diverting ileostomy, subtotal colectomy, or a thromboembolic event during index admission, and IV antibiotics or restricted diet at discharge were associated with readmission. After adjustment, patients with congestive heart failure or chronic obstructive pulmonary disease were more likely to be readmitted (aOR 4.06 and 2.86, respectively). Underweight or obese patients were nearly twice as likely to be readmitted (aOR 1.81 and 1.72, respectively). Those with past steroid use, new ileostomy, or those who were discharged on hyperalimentation were twice as likely to be readmitted (aOR 1.90, 2.04, and aOR 1.97, respectively). CONCLUSIONS: Nineteen percentage of patients with inflammatory bowel disease treated at a referral center are readmitted within 30 days. Our results suggest that patients with comorbid medical conditions, malnutrition or obesity, a new ileostomy, past steroid use, or those discharged on hyperalimentation are at increased risk for readmission. Research is needed to determine if targeted interventions for high-risk patients decreases readmissions.
No takes yet. Share an insight, caveat, or question.
Christian et al. (2017) conducted a cohort in inflammatory bowel disease (n=498). Comorbidities and clinical factors (e.g., congestive heart failure, COPD, malnutrition, new ileostomy) vs. Absence of these risk factors was evaluated on 30-day readmission (aOR 4.06). Among hospitalized patients with inflammatory bowel disease, 19.1% experienced a 30-day readmission, with congestive heart failure (aOR 4.06) and COPD (aOR 2.86) strongly predicting readmission.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: